Algert Global’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.62M | Buy |
+5,620
| New | +$1.62M | 0.03% | 697 |
|
|
2023
Q3 | – | Sell |
-5,933
| Closed | -$1.31M | – | 1263 |
|
|
2023
Q2 | $1.31M | Buy |
5,933
+400
| +7% | +$88.3K | 0.06% | 561 |
|
|
2023
Q1 | $1.24M | Sell |
5,533
-19,001
| -77% | -$4.25M | 0.06% | 550 |
|
|
2022
Q4 | $6.82M | Sell |
24,534
-712
| -3% | -$198K | 0.38% | 24 |
|
|
2022
Q3 | $5.29M | Buy |
25,246
+6,018
| +31% | +$1.26M | 0.32% | 37 |
|
|
2022
Q2 | $4.53M | Sell |
19,228
-3,124
| -14% | -$736K | 0.34% | 29 |
|
|
2022
Q1 | $4.01M | Buy |
22,352
+15,748
| +238% | +$2.83M | 0.26% | 59 |
|
|
2021
Q4 | $1.43M | Buy |
6,604
+1,760
| +36% | +$380K | 0.18% | 159 |
|
|
2021
Q3 | $894K | Buy |
+4,844
| New | +$894K | 0.12% | 286 |
|
|
2021
Q1 | – | Sell |
-2,320
| Closed | -$352K | – | 538 |
|
|
2020
Q4 | $352K | Buy |
+2,320
| New | +$352K | 0.1% | 281 |
|
|
2020
Q3 | – | Sell |
-4,850
| Closed | -$587K | – | 490 |
|
|
2020
Q2 | $587K | Sell |
4,850
-15,449
| -76% | -$1.87M | 0.2% | 162 |
|
|
2020
Q1 | $1.93M | Buy |
+20,299
| New | +$1.93M | 0.81% | 14 |
|
|
2014
Q1 | – | Sell |
-6,000
| Closed | -$678K | – | 374 |
|
|
2013
Q4 | $678K | Buy |
+6,000
| New | +$678K | 0.18% | 187 |
|